Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis

Hepatology

Volumn 70, Issue 3, 2019, Pages 925-938

  Muñoz, Leticia ^a,b   Borrero, María José ^a,b   Úbeda, María ^a,b   Conde, Elisa ^c   del Campo, Rosa ^c   Rodríguez Serrano, Macarena ^c   Lario, Margaret ^a,b   Sánchez Díaz, Ana María ^c   Pastor, Oscar ^c   Díaz, David ^a,b,d   García Bermejo, Laura ^c   Monserrat, Jorge ^a,b,d   Álvarez Mon, Melchor ^a,b,d   Albillos, Agustín ^a,b,c  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; DNA 16S; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17F; MESSENGER RNA; NORFLOXACIN; PHENOBARBITAL; RECOMBINANT DNA; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR; UVOMORULIN; VANCOMYCIN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASCITES; B LYMPHOCYTE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL MICROBIOME; BACTERIAL TRANSLOCATION; BACTERIUM CULTURE; BACTEROIDETES; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CD3+ T LYMPHOCYTE; CELL CULTURE TECHNIQUE; CLINICAL PROTOCOL; CLOSTRIDIUM; CYTOKINE PRODUCTION; DECONTAMINATION; DISCRIMINANT ANALYSIS; DYSBIOSIS; ESCHERICHIA; FLOW CYTOMETRY; ILEUM; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTESTINAL IMMUNE DYSREGULATION; INTESTINE FLORA; INTESTINE MUCOSA; INTRAEPITHELIAL LYMPHOCYTE; LAMINA PROPRIA; LIVER CIRRHOSIS; LIVER INJURY; LYMPHOCYTE; MESENTERY LYMPH NODE; MICROFLORA; MRNA EXPRESSION LEVEL; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN EXPRESSION LEVEL; PROTEOBACTERIA; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SHIGELLA; SMALL INTESTINE; T LYMPHOCYTE; TH1 CELL; UPREGULATION; ADAPTIVE IMMUNITY; ANIMAL; DISEASE MODEL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MALE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; WISTAR RAT;

ADAPTIVE IMMUNITY; ANIMALS; ASCITES; BACTERIAL TRANSLOCATION; CYTOKINES; DISEASE MODELS, ANIMAL; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; INTESTINAL MUCOSA; LIVER CIRRHOSIS; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 85062538332     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.30349     Document Type: Article

References (30)

1. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012;336:1268-1273.
2. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013;500:232-236.
3. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011;474:298-306.
4. Wiest R, Albillos A, Trauner M, Bajaj JS, Jalan R. Targeting the gut–liver axis in liver disease. J Hepatol 2017;67:1084-1103.
5. Chen P, Stärkel P, Turner JR, Ho SB, Schnabl B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology 2015;61:883-894.
6. Yan AW, Fouts DE, Brandl J, Stärkel P, Torralba M, Schott E, et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011;53:96-105.
7. Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S, et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 2010;5:e12191.
8. Zheng H, Chen M, Li Y, Wang Y, Wei L, Liao Z, et al. Modulation of gut microbiome composition and function in experimental colitis treated with sulfasalazine. Front Microbiol 2017;8:1703.
9. Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in rats with cirrhosis with ascites. Gastroenterology 1995;108:1835-1841.
10. Llovet JM, Bartolí R, Planas R, Cabré E, Jimenez M, Urban A, et al. Bacterial translocation in rats with cirrhosis. Its role in the development of spontaneous bacterial peritonitis. Gut 1994;35:1648-1652.
11. Du Plessis J, Vanheel H, Janssen CE, Roos L, Slavik T, Stivaktas PI, et al. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol 2013;58:1125-1132.
12. 4-induced liver cirrhosis by regulating T cells in rats. Sci Rep 2017;7:40516.
13. Muñoz L, Borrero MJ, Ubeda M, Lario M, Díaz D, Francés R, et al. Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis. Hepatology 2012;56:1861-1869.
14. Úbeda M, Muñoz L, Borrero MJ, Díaz D, Francés R, Monserrat J, et al. Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis. Hepatology 2010;52:2086-2095.
15. Maggi L, Santarlasci V, Capone M, Rossi MC, Querci V, Mazzoni A, et al. Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells. Eur J Immunol 2012;42:3180-3188.
16. Cosmi L, Santarlasci V, Maggi L, Liotta F, Annunziato F. Th17 plasticity: pathophysiology and treatment of chronic inflammatory disorders. Curr Opin Pharmacol 2014;17:12-16.
17. + T cell precursor. J Exp Med 2008;205:1903-1916.
18. Favre D, Lederer S, Kanwar B, Ma ZM, Proll S, Kasakow Z, et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 2009;5:e1000295.
19. Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008;4:337-349.
20. Zufferey C, Erhart D, Saurer L, Mueller C. Production of interferon-gamma by activated T-cell receptor-alphabeta CD8alphabeta intestinal intraepithelial lymphocytes is required and sufficient for disruption of the intestinal barrier integrity. Immunology 2009;128:351-359.
21. Constandinou C, Henderson N, Iredale JP. Modeling liver fibrosis in rodents. Methods Mol Med 2005;117:237-250.
22. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 2005;166:409-419.
23. Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB, et al. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology 2009;136:551-563.
24. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008;8:337-348.
25. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010;10:479-489.
26. Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol 2014;121:91-119.
27. Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 2017;19:29-41.
28. Francés R, Chiva M, Sánchez E, González-Navajas JM, Llovet T, Zapater P, et al. Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites. J Hepatol 2007;46:797-803.
29. Úbeda M, Lario M, Muñoz L, Borrero MJ, Rodríguez-Serrano M, Sánchez-Díaz AM, et al. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in rats with cirrhosis. J Hepatol 2016;64:1049-1057.
30. Schwabl P, Hambruch E, Seeland BA, Hayden H, Wagner M, Garnys L, et al. The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction. J Hepatol 2017;66:724-733.